Persistent URL of this record https://hdl.handle.net/1887/103578
In Collections
This item can be found in the following collections:
![Sarilumab, a fully human monoclonal antibody against IL-6R alpha in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Sarilumab, a fully human monoclonal antibody against IL-6R alpha in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
- All authors
- Huizinga, T.W.J.; Fleischmann, R.M.; Jasson, M.; Radin, A.R.; Adelsberg, J. van; Fiore, S.; Huang, X.H.; Yancopoulos, G.D.; Stahl, N.; Genovese, M.C.
- Date
- 2014-09-30
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 73
- Issue
- 9
- Pages
- 1626 - 1634